Osteoarthritis Trial, Recruiting (NCT06025448)

Osteoarthritis Trial, Recruiting NCT06025448 Sponsor: Lovisenberg Diakonale Hospital Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT06025448 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are scheduled to have a primary reverse shoulder replacement surgery due to osteoarthritis, a large rotator cuff tear, a failed rotator cuff repair, or shoulder instability that has led to arthritis
People whose shoulder socket bone has significantly shifted inward (a condition called massive glenoid medialization)
People who are able to read or write in Norwegian

Who may not be able to join:

People with severe bone thinning (osteoporosis)
People with bone tissue death in the upper arm bone (the ball part of the shoulder joint)
People living with dementia
People whose deltoid muscle (the main shoulder muscle used after this type of surgery) does not work well
People who are having a repeat or revision shoulder replacement surgery, rather than a first-time procedure
People classified as ASA IV, meaning they have a severe medical condition that poses a constant threat to life (confirm with trial site)
People where a long-standing infection in the shoulder is suspected
People with a recent, sudden shoulder fracture

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sigbjørn Dimmen, Prof., University of Oslo

Phone: +4790515843

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06025448

Sponsor: Lovisenberg Diakonale Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Osteoarthritis

Trial contact: +4790515843

More information: https://clinicaltrials.gov/study/NCT06025448

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are scheduled to have a primary reverse shoulder replacement surgery due to osteoarthritis, a large rotator cuff tear, a failed rotator cuff repair, or shoulder instability that has led to arthritis
People whose shoulder socket bone has significantly shifted inward (a condition called massive glenoid medialization)
People who are able to read or write in Norwegian

Who may not be able to join:

People with severe bone thinning (osteoporosis)
People with bone tissue death in the upper arm bone (the ball part of the shoulder joint)
People living with dementia
People whose deltoid muscle (the main shoulder muscle used after this type of surgery) does not work well
People who are having a repeat or revision shoulder replacement surgery, rather than a first-time procedure
People classified as ASA IV, meaning they have a severe medical condition that poses a constant threat to life (confirm with trial site)
People where a long-standing infection in the shoulder is suspected
People with a recent, sudden shoulder fracture

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Lovisenberg Diakonale Hospital

Registry

ClinicalTrials.gov

Start date

30 October 2023

Est. completion

1 March 2033

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Migration of glenoid component from baseline until 24 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov